HF
PYPD icon

HRT Financial’s PolyPid PYPD Stock Holding History

HRT Financial’s Portfolio PYPD Stock Details PYPD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Buy
+37,304
New +$172K ﹤0.01% 3417

Other funds holding PYPD

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial's PYPD Position: Q2 2026 in Review

HRT Financial opened a new position in PolyPid (PYPD) in Q2 2026: 37,304 shares worth $189K. The stake represents ﹤0.01% of the portfolio and ranks #3417 among its holdings.

33 funds tracked by Wall St. Rank hold PYPD as of Q2 2026.

  • HRT Financial held 37,304 shares of PolyPid worth $189K as of Q2 2026.
  • PolyPid was a new HRT Financial position in Q2 2026.
  • PolyPid made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3417 holding.
  • 33 funds tracked by Wall St. Rank held PolyPid as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.